Read + Share
Zhou A, Srinivasan A, Vasudevan A. Biologic choice should be guided by disease severity not malignancy in patients
with inflammatory bowel disease. Clin Gastroenterol Hepatol 2023 Aug 3:S1542-3565(23)00581.
PMID: 37543103
|
 |
|
Zhou A, Srinivasan A, Vasudevan A. Biologic choice should be guided by disease severity not malignancy in patients
with inflammatory bowel disease. Clin Gastroenterol Hepatol 2023 Aug 3:S1542-3565(23)00581.
PMID: 37543103
|
|
|
|